The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Efficacy and Safety of Ephedra and Ephedrine for Weight Loss and Athletic Performance: A Meta-analysis
Open accessAbstract
Context: Ephedra and ephedrine sometimes are used for weight loss or enhanced athletic performance, but the efficacy and safety of these compounds are uncertain. Objective: To assess the efficacy and safety of ephedra and ephedrine used for weight loss and enhanced athletic performance. Data Sources: We searched 9 databases using the terms ephedra , ephedrine , adverse effect , side effect , efficacy , effective , and toxic . We included unpublished trials and non–English-language documents. Adverse events reported to the US Food and Drug Administration MedWatch program were assessed. Study Selection: Eligible studies were controlled trials of ephedra or ephedrine used for weight loss or athletic performance and case reports of adverse events associated with such use. Eligible studies for weight loss were human studies with at least 8 weeks of follow-up; and for athletic performance, those having no minimum follow-up. Eligible case reports documented that ephedra or ephedrine was consumed within 24 hours prior to an adverse event or that ephedrine or an associated product was found in blood or urine, and that other potential causes had been excluded. Of the 530 articles screened, 52 controlled trials and 65 case reports were included in the adverse events analysis. Of more than 18 000 other case reports screened, 284 underwent detailed review. Data Extraction: Two reviewers independently identified trials of efficacy and safety of ephedra and ephedrine on weight loss or athletic performance; disagreements were resolved by consensus. Case reports were reviewed with explicit and implicit methods. Data Synthesis: No weight loss trials assessed duration of treatment greater than 6 months. Pooled results for trials comparing placebo with ephedrine (n = 5), ephedrine and caffeine (n = 12), ephedra (n = 1), and ephedra and herbs containing caffeine (n = 4) yielded estimates of weight loss (more than placebo) of 0.6 (95% confidence interval, 0.2-1.0), 1.0 (0.7-1.3), 0.8 (0.4-1.2), and 1.0 (0.6-1.3) kg/mo, respectively. Sensitivity analyses did not substantially alter the latter 3 results. No trials of ephedra and athletic performance were found; 7 trials of ephedrine were too heterogeneous to synthesize. Safety data from 50 trials yielded estimates of 2.2- to 3.6-fold increases in odds of psychiatric, autonomic, or gastrointestinal symptoms, and heart palpitations. Data are insufficient to draw conclusions about adverse events occurring at a rate less than 1.0 per thousand. The majority of case reports are insufficiently documented to allow meaningful assessment. Conclusions: Ephedrine and ephedra promote modest short-term weight loss (≈0.9 kg/mo more than placebo) in clinical trials. There are no data regarding long-term weight loss, and evidence to support use of ephedra for athletic performance is insufficient. Use of ephedra or ephedrine and caffeine is associated with increased risk of psychiatric, autonomic, or gastrointestinal symptoms, and heart palpitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unfortunately, ephedrine is associated with increased risk of psychiatric, autonomic, gastrointestinal, and cardiovascular symptoms 134, which likely will preclude the use of ephedrine itself for the treatment of obesity.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [134]
In the citing paper
“A meta-analysis of several dozen trials showed that ephedrine promotes modest short-term weight loss, but there are no data on longer-term efficacy 134.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [134]
In the citing paper
“Unfortunately, ephedrine is associated with increased risk of psychiatric, autonomic, gastrointestinal, and cardiovascular symptoms 134, which likely will preclude the use of ephedrine itself for the treatment of obesity.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Higgins (2002) · doi:10.1002/(issn)1097-0258 · Cited by 1,248
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
A random‐effects regression model for meta‐analysis
Berkey, C. S., Hoaglin, D. C., Mosteller, F. C., & Colditz, G. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140406 · Cited by 896
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1108 · Cited by 287 · cited 8×
“Molnar et al,27 2000 4 Ephedrine (30-60) and caffeine (100 for 1 wk) 20 wk 16 16 0.”
InfluentialLong-term Weight Loss With Sibutramine
Wirth, A. G., & Krause, J. (2001) · JAMA · doi:10.1001/jama.286.11.1331 · Cited by 267
Research works printed but not linked: 13
- Abrahamson, 2001, Wheeler used supplement., Los Angeles Times
- Carey, 2001, Risks of ephedra usage in spotlight., Los Angeles Times
- Marsa, 2002, A tug of war in a larger battle: ephedra is now under intense scrutiny., Los Angeles Times
- Moheb, 1998, Effect of ephedrine, caffeine, and aspirin, in combinations of weight loss in obese women [abstract]., Int J Obes Relat Metab Disord, 22, S264
- Colker, 2001, A pilot study evaluating the effects of an ephedrine and forskolin-based product on body weight and body composition in overweight, healthy women [abstract]., J Am Coll Nutr, 20, 98
- Jensen, 1980, Elsinore tablets and ephedrine as slimming agents [in Danish]., Ugeskr Laeger, 142, 1499
- Kettle, 1998, Ephedrine/caffeine enhances abdominal fat loss in females., Int J Obes Relat Metab Disord, 22, S264
- Lumholtz, 1980, Ephedrine in the treatment of obesity [in Danish]., Ugeskr Laeger, 142, 1487
- Quaade, 1992, The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet [in Danish]., Ugeskr Laeger, 154, 1258
- Roed, 1980, Elsinore banting tablets [in Danish]., Ugeskr Laeger, 142, 1491
- Breum, 1994, Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity., Int J Obes Relat Metab Disord, 18, 99
- Not Available, 2001, >Stata [computer program].
- Not Available, 2000, StatXact 4 [computer program].
Cited by
Sorted by citations
Items 301–400 of 511
Dietary Supplements for Weight Loss
Heymsfield, S. B. (2023) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2023.03.010 · Cited by 7
McBride, B. F., Guertin, D. C., White, C. M., & Kluger, J. (2004) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2004.00627.x · Cited by 7
Herbal Weight-Loss Supplement Misadventures Per a Regional Poison Center
Robinson, R. F., Griffith, J. R. K., Nahata, M. C., Mahan, J. D., & Casavant, M. J. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d260 · Cited by 7
Liver Disease Caused by Anesthetics, Toxins, and Herbal Preparations
Lewis, J. H. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00087-1 · Cited by 7
The Relative Safety of Ephedra Compared with Other Herbal Products
Kimmel, S. E. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-3-200308050-00020 · Cited by 7
Spanakis, M., Bakaros, E., Papadopoulou, S.-N., Fournaraki, A., & Symvoulakis, E. K. (2025) · Pharmacoepidemiology · doi:10.3390/pharma4040022 · Cited by 6
Mood symptoms in steroid users: the unexamined role of concurrent stimulant use
Sanjuan, P. M., Langenbucher, J. L., & Hildebrandt, T. (2015) · Journal of Substance Use · doi:10.3109/14659891.2015.1040089 · Cited by 6
Ventricular Tachycardia Induced by Weight Loss Pills
Pareek, M., Hansson, N. H., & Grove, E. L. (2013) · Case Reports in Medicine · doi:10.1155/2013/712383 · Cited by 6
An Integrative Approach to Obesity
Nicolai, J. P., Lupiani, J. H., & Wolf, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00038-8 · Cited by 6
Kibathi, L. W., Bae, S., Penzak, S. R., & Kumar, P. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0486-6 · Cited by 6
Wu, X., McLaughlin, L. D., Polk, J. P., Chalasani, M., Greenway, F. L., & Zheng, J. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9963-y · Cited by 6
Statistical collaboration to impact policy decisions
Morton, S. C. (2005) · Statistics in Medicine · doi:10.1002/sim.2075 · Cited by 6
Self-citationPark, W. Y., Song, G., Boo, M., Kim, H. I., Park, J. Y., Jung, S. J., Choi, M., Kim, B., Kim, Y. D., Kim, M., et al. (2022) · Antioxidants · doi:10.3390/antiox12010049 · Cited by 5
Modulation of obesity by Gyeongshingangjeehwan18 in ob/ob mice
Yoon, K.-H., Lee, H., Jung, Y.-S., Seo, B.-I., Park, G.-R., Yoon, M., & Shin, S.-S. (2010) · The Korea Journal of Herbology · doi:10.6116/kjh.2010.25.3.001 · Cited by 5
Principles of Energy Homeostasis
Ahima, R. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_48-1 · Cited by 5
Pruitt, R. H., Lemanski, A., & Carroll, A. (2018) · The Nurse Practitioner · doi:10.1097/01.npr.0000531919.99762.85 · Cited by 5
Yoon, S.-H., Lee, E., Jo, H.-J., Han, Y., Kim, H., Yun, Y., Choi, Y., Park, J.-S., & Leem, J. (2020) · Journal of Korean Medicine for Obesity Research · doi:10.15429/jkomor.2020.20.1.31 · Cited by 5
Caffeine, Creatine, and Food–Drug Synergy: Ergogenics and Applications to Human Health
Graham, T. E., & Moisey, L. L. (2005) · CRC Press eBooks · doi:10.1201/9781420038255-17 · Cited by 5
Westanmo, A. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-383-7_15 · Cited by 5
Thermogenic Supplement Use Does Not Alter Characteristics of Sudden Death in the Young
Appel, D. A., McNear, J., Shry, E. A., Gentlesk, P. J., Reich, S., & Eckart, R. E. (2012) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2012.03510.x · Cited by 5
Dietary Supplements in the Department of Defense: Possible Solutions to Optimizing Force Readiness
Gonsalves, S. G., Stavinoha, T., Hite, L., Costa, J., Dilly, G. A., & Deuster, P. A. (2012) · Military Medicine · doi:10.7205/milmed-d-12-00249 · Cited by 5
Integrative Health and Medicine: Dietary Supplements and Modalities for the Treatment of Obesity
Nuffer, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816093-0.00027-6 · Cited by 5
Onakpoya, I., Davies, L., & Ernst, E. (2011) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2011.01115.x · Cited by 5
Emerging Patterns in Dietary Supplement Use Among US Adults, 1999-2023
Lam, C. S., O’Connell, K., Monroy‐Iglesias, M. J., Wang, P., Hou, Y.-N., Du, M., Giovannucci, E. L., Mao, J. J. J., & Kantor, E. D. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.19291 · Cited by 4
Ghosh, S. B., Vunduk, J., Mahmud, N., Rejab, N. A., Ikram, N. K. K., Wan‐Mohtar, W. A. A. Q. I., Ghosh, S., Alkafaas, S. S., AlHuchaimi, S. N., Gafforov, Y., et al. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100208 · Cited by 4
Ahmed, A., Ahmad, R., Jangir, S., & Sharma, D. (2024) · The Natural Products Journal · doi:10.2174/0122103155281428240320091344 · Cited by 4
Citrus aurantium: Phytochemistry, Therapeutic Potential, Safety Considerations, and Research Needs
Ogunro, O. B., Richard, G., Izah, S. C., Ovuru, K. F., Babatunde, O. T., & Das, M. (2024) · Reference series in phytochemistry · doi:10.1007/978-3-031-43199-9_69 · Cited by 4
Valente, A. J. M., Filho, C. M. C., Rubira, A. F., Muniz, E. C., & Burrows, H. D. (2014) · Colloid & Polymer Science · doi:10.1007/s00396-014-3227-7 · Cited by 4
Anti-obesity Effects of Galgeun-tang in High Fat Diet Induced Obese Mice Model
Ki, S.-H., Kim, H., Ko, S., & Song, Y.-K. (2016) · Journal of Korean Medicine Rehabilitation · doi:10.18325/jkmr.2016.26.2.13 · Cited by 4
Hepatic Injury due to Drugs, Dietary and Herbal Supplements, Chemicals and Toxins
Kleiner, D. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00012-0 · Cited by 4
Citrus aurantium: Phytochemistry, Therapeutic Potential, Safety Considerations, and Research Needs
Ogunro, O. B., Richard, G., Izah, S. C., Ovuru, K. F., Babatunde, O. T., & Das, M. (2023) · Reference series in phytochemistry · doi:10.1007/978-3-031-21973-3_69-1 · Cited by 4
Dopage et compléments alimentaires
Fouillot, J.-P. (2005) · Science & Sports · doi:10.1016/j.scispo.2005.01.007 · Cited by 4
Foran, B. J. (2007) · Cited by 4
Dietary Supplement Interactions With Medication
Mucksavage, J. J., & Chan, L. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-781-9_11 · Cited by 4
McCarthy, C. E., Candelario, D. M., & Liu, M. T. (2014) · Pharmacology & Pharmacy · doi:10.4236/pp.2014.510109 · Cited by 4
Ruxton, C. H. S., & Gardner, E. J. (2005) · British Food Journal · doi:10.1108/00070700510579180 · Cited by 4
Ephedra use in a select group of adolescent athletes.
Schaefer, M. P., Smith, J., Dahm, D. L., & Sorenson, M. C. (2006) · Europe PMC (PubMed Central) · Cited by 4
Bray, G. A., & Greenway, F. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-400-1_18 · Cited by 4
Song, M., Bose, S., Kim, H., Lee, M.-J., & Lim, C. (2012) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2012.03.002 · Cited by 4
Dopage et compléments alimentaires
Fouillot, J.-P. (2004) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)33710-0 · Cited by 4
Puma, J. L., Szapary, P. O., & Maki, K. C. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.7.806 · Cited by 4
Thuyne, W. V. (2006) · Ghent University Academic Bibliography (Ghent University) · Cited by 4
Effects of congeners of amphetamine on the human heart
Neumann, J., Dhein, S., Kirchhefer, U., Hofmann, B., & Gergs, U. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-02983-2 · Cited by 3
Pharmacotherapy for Psychotropic Drug-Related Weight Gain
Howland, R. H. (2008) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20080701-06 · Cited by 3
An, H., Rim, H.-K., Suh, S.-E., Jeong, H., Um, J., Hong, S., & Kim, H. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903335108 · Cited by 3
The Research Progress and Application Prospect of Uncoupling Protein 1 (UCP1)
高, 文. (2012) · Bioprocess · doi:10.12677/bp.2012.23021 · Cited by 3
Phendimetrazine-Induced Persistent Psychosis: A Case Report
Vartak, S., Varadarajulu, R. N., Sadeghzadeh, M., & Bodic, M. (2021) · Psychiatric Annals · doi:10.3928/00485713-20210909-01 · Cited by 3
Weight Loss Nutritional Supplements
Eckerson, J. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-18230-8_8 · Cited by 3
Interaction of Natural Products with Medication and Nutrients
Chan, L. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-362-6_12 · Cited by 3
Seok, H. J., Yoo, J. S., Ku, J. R., Yoon, K. H., Jo, J. H., Jang, D. H., Jung, Y. S., Kim, J., Kim, B. C., Roh, J. S., et al. (2014) · Herbal Formula Science · doi:10.14374/hfs.2014.22.2.105 · Cited by 3
Traditional Chinese Herbal Medicine – East Meets West in Validation and Therapeutic Application
John, W. M., Sonny, H. M., & Yung, J. Y. K. (2012) · InTech eBooks · doi:10.5772/26606 · Cited by 3
Drug Abuse in Cardiovascular Diseases
Furlanello, F., Serdoz, L. V., AMBROGGI, L. D., & Cappato, R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_32 · Cited by 3
Yoo, J. S., Ku, J. R., Yoon, K. H., Jo, J. H., Jang, D. H., Jung, Y. S., Kim, J., Kim, B. C., Seok, H. J., Yoon, M., et al. (2015) · Journal of Korean Medicine for Obesity Research · doi:10.15429/jkomor.2015.15.1.9 · Cited by 3
RetractedThe Management of Eating Disorders and Obesity
GOLDSTEIN, D. J. (2005) · Humana Press eBooks · doi:10.1385/159259865x · Cited by 3
The Relative Safety of Ephedra Compared with Other Herbal Products
Bent, S., Tiedt, T. N., Odden, M. C., & Shlipak, M. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-12-200306170-00019 · Cited by 3
The potential use of ephedrine in Lambert-Eaton myasthenic syndrome
Cereda, C. W., & Küntzer, T. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0856-0 · Cited by 3
Herbaceuticals: An Overview for Counselors
Ingersoll, R. (2005) · Journal of Counseling & Development · doi:10.1002/j.1556-6678.2005.tb00365.x · Cited by 3
Drugs Used Clinically to Reduce Body Weight
Bray, G. A. (2009) · Wiley eBooks · doi:10.1002/9781444307627.ch24 · Cited by 3
Dietary Supplements: Policy and Research Implications for Nurses
Xue, Y., & Cohen, S. S. (2004) · Policy Politics & Nursing Practice · doi:10.1177/1527154404266586 · Cited by 3
Complementary and alternative medicine: the facts.
Grossman, E. (2005) · PubMed · Cited by 3
Magkos, F., & Kavouras, S. A. (2004) · CRC Press eBooks · doi:10.1201/9780203507704.ch17 · Cited by 4
&NA; (2006) · Drugs & Therapy Perspectives · doi:10.2165/00042310-200622010-00003 · Cited by 3
Abdul-Ameer, L. A., Mikhael, E. M., & Lua, P. L. (2025) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-025-00497-4 · Cited by 2
Influence of Galgeun-tang on Gene Expression in Diet-Induced Obese Mice
Ye, S.-A., Kim, H., Ko, S., & Song, Y.-K. (2016) · Journal of Korean Medicine Rehabilitation · doi:10.18325/jkmr.2016.26.2.1 · Cited by 2
Dorion, J., & Dumas, J. (2010) · Les Presses de l'Université de Montréal eBooks · doi:10.4000/books.pum.6563 · Cited by 2
Rebello, C. J., Greenway, F. L., Zhang, D., Johnson, W. D., Patterson, E., & Raum, W. J. (2022) · Obesity · doi:10.1002/oby.23384 · Cited by 2
Appearance and Performance Enhancing Drugs and Substances: The Role of the School Nurse
Siegmund, L. A. (2022) · NASN School Nurse · doi:10.1177/1942602x221093938 · Cited by 2
Integrative medicine in neurology
Subramanian, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00018-6 · Cited by 2
Principles of Energy Homeostasis
Ahima, R. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_48 · Cited by 2
Effect and mechanisms of Gambi-jung against high-fat diet-induced cardiac apoptosis in mice
Park, Y., Kim, H.-J., Koh, D.-J., Kim, E., Lim, Y.-W., & An, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29161 · Cited by 2
Mullin, G. E. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615578918 · Cited by 2
Gangjihwan Reduces Body Weight Gain in a ob/ob Female Mice
Baek, S. Y., Lee, H. R., Park, J. H., Yoon, M., Yoon, Y., Yang, H.-J., Choi, Y. H., & Shin, S. S. (2017) · Herbal Formula Science · doi:10.14374/hfs.2017.25.2.193 · Cited by 2
Kim, B. C., Seok, H. J., Yoo, J. S., Ku, J. R., Yoon, K. H., Jo, J. H., Jang, D. H., Jung, Y. S., Kim, J., Ahn, Y. J., et al. (2014) · Herbal Formula Science · doi:10.14374/hfs.2014.22.2.063 · Cited by 2
CrossRef Listing of Deleted DOIs
Keisler, B. D., & Hosey, R. G. (2007) · CrossRef Listing of Deleted DOIs · doi:10.1007/s11932-005-0042-4 · Cited by 2
Another Type of Intervention: Treating Obesity with Medication
Greenway, F. L. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2005.03.004 · Cited by 2
Norton, R., Lehnhard, R. A., Kearns, C. F., & McKeever, K. H. (2013) · Comparative Exercise Physiology · doi:10.3920/cep12021 · Cited by 2
Suplementos dietéticos para reducir de peso: dilemas médicos y éticos
Vásquez, F., & López, J. V. (2014) · Revista médica de Chile · doi:10.4067/s0034-98872014000800016 · Cited by 2
Bebidas energizantes, educación social y salud
y Machorro, M. S., & Moreno, L. C. (2007) · Cited by 2
Vegetables as new psychoactive drugs: a narrative review
Salgado, B. R., Gómez-Arnau, J., Mateos, D. S., & Dolengevich-Segal, H. (2016) · Medwave · doi:10.5867/medwave.2016.01.6372 · Cited by 2
Commonly Prescribed Oral Anti-Obesity Medication and Alternative Anorectics
Baker, J. S., Davies, B., & Graham, M. R. (2016) · Palgrave Macmillan UK eBooks · doi:10.1057/978-1-137-53535-1_10 · Cited by 2
Solid-Phase and Oscillating Solution Crystallization Behavior of (+)- and (−)- N -Methylephedrine
Tulashie, S. K., Polenske, D., Seidel‐Morgenstern, A., & Lorenz, H. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.08.005 · Cited by 2
A Case Report of Increased Blood Sugar in a Diabetic Patient Treated with Socheongryong-tang
Kim, Y., Song, J., Hong, S., Park, S.-W., Kim, H., Ahn, L., & Choi, D.-J. (2019) · The Journal of Internal Korean Medicine · doi:10.22246/jikm.2019.40.5.929 · Cited by 2
Herbal preparations for weight loss in adults
Teng, L., Lee, E. L., Zhang, L., & Barnes, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013576 · Cited by 2
OTHER ARTICLES NOTED(25 Apr 2003 to 18 Jul 2003)
(2003) · Evidence-Based Nursing · doi:10.1136/ebn.6.4.e1 · Cited by 2
Principles of Energy Homeostasis
Ahima, R. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_48 · Cited by 2
Tang, J., Zhou, X., Ji, H., Xu, N., Liu, H., Lan, G., & Wu, L. (2011) · Chromatographia · doi:10.1007/s10337-011-1950-5 · Cited by 2
Synthesis, Structure and Biological Activity of Ephedra Heterocycles
Cruz, A., Martínez, I. I. P., & Ramirez, M. E. B. (2017) · InTech eBooks · doi:10.5772/67387 · Cited by 2
Haub, M. D. (2004) · CRC Press eBooks · doi:10.1201/9780203507704.pt4 · Cited by 2
Magalhães, L. M., de Oliveira, C. V. C., Gonçalves, M. D. C. R., de Souza, A. A., & Silva, A. S. (2013) · Journal of Pharmacy and Nutrition Sciences · doi:10.6000/1927-5951.2013.03.02.3 · Cited by 1
“[10] found 16,000 adverse events associated with the use of ephedrine contained in dietary supplements.”
BackgroundNishi, A., Hyuga, S., Hyuga, M., Uema, M., Uchiyama, N., Odaguchi, H., & Goda, Y. (2025) · Microorganisms · doi:10.3390/microorganisms13040830 · Cited by 1
Meng, L., & Rasmussen, M. (2025) · Anesthesiology · doi:10.1097/aln.0000000000005532 · Cited by 1
Risks Involved in the Use of Herbal Products
Kaufman, P. B., McKenzie, M., & Kirakosyan, A. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0194-1_14 · Cited by 1
Perceptions related to dietary supplements among college students
Brown, B. R., Kavanagh, K., Paulus, T. M., & Spence, M. (2011) · The FASEB Journal · doi:10.1096/fasebj.25.1_supplement.989.23 · Cited by 1
Impact of Missing Data and Imputation Methods on Multiple Test Procedures
Indurkhya, A. (2005) · Birkhäuser Boston eBooks · doi:10.1007/0-8176-4422-9_11 · Cited by 1
Weight Loss Nutritional Supplements
Eckerson, J. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-231-1_8 · Cited by 1
Drugs that affect autonomic functions or the extrapyramidal system
Schächter, M. (2008) · Side effects of drugs annual · doi:10.1016/s0378-6080(08)00013-5 · Cited by 1
The Extract of Herbal Medicines Activates AMP-Activated Protein Kinase in Diet-Induced Obese Rats
Shin, H.-Y., Chung, S., Kim, S. R., Lee, J., Seo, H., Shin, Y. C., & Ko, S. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/756025 · Cited by 1
Naik, D. D. V. R. S., & Prabhakar, D. M. (2015) · IJAR - Indian Journal of Applied Research · Cited by 1
Sudden Cardiac Deaths in Athletes, Including Commotio Cordis
Link, M. S., & Estes, N. A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00108-5 · Cited by 1
Aspects regarding the use of drugs among athletes
Gligor, Ş., & Gligor, R. (2018) · Timisoara Physical Education and Rehabilitation Journal · doi:10.2478/tperj-2018-0007 · Cited by 1
Metadata
- Authors
- Shekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A., Suttorp, M. J., Rhodes, S. L., Jungvig, L., & Gagné, J.
- Affiliations
- RAND Corporation (US)
- Cedars-Sinai Medical Center (US)
- University of Southern California (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-03-26
- Volume
- 289
- Issue
- 12
- Pages
- 1537
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1999289755
- Cited by
- 511
- References
- 43
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 10 · 2023: 11 · 2022: 15 · 2021: 15 · 2020: 9 · 2019: 15 · 2018: 16 · 2017: 16 · 2016: 19 · 2015: 21 · 2014: 20 · 2013: 17 · 2012: 23
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- VTechWorks (Virginia Tech) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Health Services Research and Development
- U.S. Public Health Service (290-97-0001)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Social Sciences › Sociology and Political Science › Doping in Sports
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Keywords
- Ephedra, ephedrine, weight loss, athletic performance, stimulants, caffeine, adverse events, drug safety, efficacy, herbal supplements, performance-enhancing drugs
- MeSH terms
- Caffeine, Ephedrine, Humans, Physical Endurance, Risk, Sports, Weight Loss, Randomized Controlled Trials as Topic, Controlled Clinical Trials as Topic, Anti-Obesity Agents, Dietary Supplements, Plant Preparations, Ephedra
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review